APO Research
Talk to an analyst

APO RESEARCH · REPORT

Iguratimod

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Iguratimod Market Analysis and Forecast 2026-2032

23 December 2025196 pages

Choose your research edition.

Industry ResearchIguratimod Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Iguratimod Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Iguratimod Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Iguratimod Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Iguratimod Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Iguratimod market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Iguratimod is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Iguratimod is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Iguratimod is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Iguratimod is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Iguratimod include Simcere Pharmaceutical, Eisai and Toyama Chemical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Iguratimod, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Iguratimod, also provides the sales of main regions and countries. Of the upcoming market potential for Iguratimod, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Iguratimod sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Iguratimod market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Iguratimod sales, projected growth trends, production technology, application and end-user industry.

Iguratimod Segment by Company

Simcere Pharmaceutical

Eisai

Toyama Chemical

Iguratimod Segment by Type

14 Pcs/Box

100 Pcs/Box

Iguratimod Segment by Application

Antirheumatic

Immunoregulation

Others

Iguratimod Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iguratimod market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Iguratimod and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iguratimod.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Iguratimod in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Iguratimod manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Iguratimod sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Iguratimod Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 14 Pcs/Box Major Manufacturers Table 3. 100 Pcs/Box Major Manufacturers Table 4. Global Iguratimod Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Antirheumatic Major Manufacturers Table 6. Immunoregulation Major Manufacturers Table 7. Others Major Manufacturers Table 8. Iguratimod Industry Trends Table 9. Iguratimod Industry Drivers Table 10. Iguratimod Industry Opportunities and Challenges Table 11. Iguratimod Industry Restraints Table 12. Global Iguratimod Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Iguratimod Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Iguratimod Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Iguratimod Revenue Market Share by Region (2021-2026) Table 16. Global Iguratimod Revenue Market Share by Region (2027-2032) Table 17. Global Iguratimod Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k pcs) Table 18. Global Iguratimod Sales by Region (2021-2026) & (k pcs) Table 19. Global Iguratimod Sales by Region (2027-2032) & (k pcs) Table 20. Global Iguratimod Sales Market Share by Region (2021-2026) Table 21. Global Iguratimod Sales Market Share by Region (2027-2032) Table 22. Global Iguratimod Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Iguratimod Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Iguratimod Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Iguratimod Sales Market Share by Manufacturers (2021-2026) Table 26. Global Iguratimod Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 27. Global Iguratimod Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Iguratimod Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Iguratimod Manufacturers, Product Type & Application Table 30. Global Iguratimod Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Iguratimod by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Iguratimod Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Iguratimod Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Iguratimod Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Iguratimod Revenue Market Share by Type (2021-2026) Table 37. Global Iguratimod Revenue Market Share by Type (2027-2032) Table 38. Global Iguratimod Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 39. Global Iguratimod Sales by Type (2021-2026) & (k pcs) Table 40. Global Iguratimod Sales by Type (2027-2032) & (k pcs) Table 41. Global Iguratimod Sales Market Share by Type (2021-2026) Table 42. Global Iguratimod Sales Market Share by Type (2027-2032) Table 43. Global Iguratimod Price by Type (2021-2026) & (US$/pcs) Table 44. Global Iguratimod Price by Type (2027-2032) & (US$/pcs) Table 45. Global Iguratimod Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Iguratimod Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Iguratimod Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Iguratimod Revenue Market Share by Application (2021-2026) Table 49. Global Iguratimod Revenue Market Share by Application (2027-2032) Table 50. Global Iguratimod Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 51. Global Iguratimod Sales by Application (2021-2026) & (k pcs) Table 52. Global Iguratimod Sales by Application (2027-2032) & (k pcs) Table 53. Global Iguratimod Sales Market Share by Application (2021-2026) Table 54. Global Iguratimod Sales Market Share by Application (2027-2032) Table 55. Global Iguratimod Price by Application (2021-2026) & (US$/pcs) Table 56. Global Iguratimod Price by Application (2027-2032) & (US$/pcs) Table 57. Simcere Pharmaceutical Company Information Table 58. Simcere Pharmaceutical Business Overview Table 59. Simcere Pharmaceutical Iguratimod Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 60. Simcere Pharmaceutical Iguratimod Product Portfolio Table 61. Simcere Pharmaceutical Recent Development Table 62. Eisai Company Information Table 63. Eisai Business Overview Table 64. Eisai Iguratimod Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 65. Eisai Iguratimod Product Portfolio Table 66. Eisai Recent Development Table 67. Toyama Chemical Company Information Table 68. Toyama Chemical Business Overview Table 69. Toyama Chemical Iguratimod Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 70. Toyama Chemical Iguratimod Product Portfolio Table 71. Toyama Chemical Recent Development Table 72. North America Iguratimod Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Iguratimod Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Iguratimod Sales by Type (2021-2026) & (k pcs) Table 75. North America Iguratimod Sales by Type (2027-2032) & (k pcs) Table 76. North America Iguratimod Sales Price by Type (2021-2026) & (US$/pcs) Table 77. North America Iguratimod Sales Price by Type (2027-2032) & (US$/pcs) Table 78. North America Iguratimod Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Iguratimod Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Iguratimod Sales by Application (2021-2026) & (k pcs) Table 81. North America Iguratimod Sales by Application (2027-2032) & (k pcs) Table 82. North America Iguratimod Sales Price by Application (2021-2026) & (US$/pcs) Table 83. North America Iguratimod Sales Price by Application (2027-2032) & (US$/pcs) Table 84. North America Iguratimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Iguratimod Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Iguratimod Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Iguratimod Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 88. North America Iguratimod Sales by Country (2021-2026) & (k pcs) Table 89. North America Iguratimod Sales by Country (2027-2032) & (k pcs) Table 90. North America Iguratimod Sales Price by Country (2021-2026) & (US$/pcs) Table 91. North America Iguratimod Sales Price by Country (2027-2032) & (US$/pcs) Table 92. United States Iguratimod Revenue (2021-2032) & (US$ Million) Table 93. Canada Iguratimod Revenue (2021-2032) & (US$ Million) Table 94. Mexico Iguratimod Revenue (2021-2032) & (US$ Million) Table 95. Europe Iguratimod Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Iguratimod Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Iguratimod Sales by Type (2021-2026) & (k pcs) Table 98. Europe Iguratimod Sales by Type (2027-2032) & (k pcs) Table 99. Europe Iguratimod Sales Price by Type (2021-2026) & (US$/pcs) Table 100. Europe Iguratimod Sales Price by Type (2027-2032) & (US$/pcs) Table 101. Europe Iguratimod Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Iguratimod Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Iguratimod Sales by Application (2021-2026) & (k pcs) Table 104. Europe Iguratimod Sales by Application (2027-2032) & (k pcs) Table 105. Europe Iguratimod Sales Price by Application (2021-2026) & (US$/pcs) Table 106. Europe Iguratimod Sales Price by Application (2027-2032) & (US$/pcs) Table 107. Europe Iguratimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Iguratimod Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe Iguratimod Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe Iguratimod Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 111. Europe Iguratimod Sales by Country (2021-2026) & (k pcs) Table 112. Europe Iguratimod Sales by Country (2027-2032) & (k pcs) Table 113. Europe Iguratimod Sales Price by Country (2021-2026) & (US$/pcs) Table 114. Europe Iguratimod Sales Price by Country (2027-2032) & (US$/pcs) Table 115. Germany Iguratimod Revenue (2021-2032) & (US$ Million) Table 116. France Iguratimod Revenue (2021-2032) & (US$ Million) Table 117. U.K. Iguratimod Revenue (2021-2032) & (US$ Million) Table 118. Italy Iguratimod Revenue (2021-2032) & (US$ Million) Table 119. Russia Iguratimod Revenue (2021-2032) & (US$ Million) Table 120. Spain Iguratimod Revenue (2021-2032) & (US$ Million) Table 121. Netherlands Iguratimod Revenue (2021-2032) & (US$ Million) Table 122. Switzerland Iguratimod Revenue (2021-2032) & (US$ Million) Table 123. Sweden Iguratimod Revenue (2021-2032) & (US$ Million) Table 124. Poland Iguratimod Revenue (2021-2032) & (US$ Million) Table 125. China Iguratimod Revenue by Type (2021-2026) & (US$ Million) Table 126. China Iguratimod Revenue by Type (2027-2032) & (US$ Million) Table 127. China Iguratimod Sales by Type (2021-2026) & (k pcs) Table 128. China Iguratimod Sales by Type (2027-2032) & (k pcs) Table 129. China Iguratimod Sales Price by Type (2021-2026) & (US$/pcs) Table 130. China Iguratimod Sales Price by Type (2027-2032) & (US$/pcs) Table 131. China Iguratimod Revenue by Application (2021-2026) & (US$ Million) Table 132. China Iguratimod Revenue by Application (2027-2032) & (US$ Million) Table 133. China Iguratimod Sales by Application (2021-2026) & (k pcs) Table 134. China Iguratimod Sales by Application (2027-2032) & (k pcs) Table 135. China Iguratimod Sales Price by Application (2021-2026) & (US$/pcs) Table 136. China Iguratimod Sales Price by Application (2027-2032) & (US$/pcs) Table 137. Asia Iguratimod Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Iguratimod Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Iguratimod Sales by Type (2021-2026) & (k pcs) Table 140. Asia Iguratimod Sales by Type (2027-2032) & (k pcs) Table 141. Asia Iguratimod Sales Price by Type (2021-2026) & (US$/pcs) Table 142. Asia Iguratimod Sales Price by Type (2027-2032) & (US$/pcs) Table 143. Asia Iguratimod Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Iguratimod Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Iguratimod Sales by Application (2021-2026) & (k pcs) Table 146. Asia Iguratimod Sales by Application (2027-2032) & (k pcs) Table 147. Asia Iguratimod Sales Price by Application (2021-2026) & (US$/pcs) Table 148. Asia Iguratimod Sales Price by Application (2027-2032) & (US$/pcs) Table 149. Asia Iguratimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Iguratimod Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Asia Iguratimod Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Asia Iguratimod Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 153. Asia Iguratimod Sales by Country (2021-2026) & (k pcs) Table 154. Asia Iguratimod Sales by Country (2027-2032) & (k pcs) Table 155. Asia Iguratimod Sales Price by Country (2021-2026) & (US$/pcs) Table 156. Asia Iguratimod Sales Price by Country (2027-2032) & (US$/pcs) Table 157. Japan Iguratimod Revenue (2021-2032) & (US$ Million) Table 158. South Korea Iguratimod Revenue (2021-2032) & (US$ Million) Table 159. India Iguratimod Revenue (2021-2032) & (US$ Million) Table 160. Australia Iguratimod Revenue (2021-2032) & (US$ Million) Table 161. Taiwan Iguratimod Revenue (2021-2032) & (US$ Million) Table 162. Southeast Asia Iguratimod Revenue (2021-2032) & (US$ Million) Table 163. SAMEA Iguratimod Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA Iguratimod Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA Iguratimod Sales by Type (2021-2026) & (k pcs) Table 166. SAMEA Iguratimod Sales by Type (2027-2032) & (k pcs) Table 167. SAMEA Iguratimod Sales Price by Type (2021-2026) & (US$/pcs) Table 168. SAMEA Iguratimod Sales Price by Type (2027-2032) & (US$/pcs) Table 169. SAMEA Iguratimod Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Iguratimod Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Iguratimod Sales by Application (2021-2026) & (k pcs) Table 172. SAMEA Iguratimod Sales by Application (2027-2032) & (k pcs) Table 173. SAMEA Iguratimod Sales Price by Application (2021-2026) & (US$/pcs) Table 174. SAMEA Iguratimod Sales Price by Application (2027-2032) & (US$/pcs) Table 175. SAMEA Iguratimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. SAMEA Iguratimod Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. SAMEA Iguratimod Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. SAMEA Iguratimod Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 179. SAMEA Iguratimod Sales by Country (2021-2026) & (k pcs) Table 180. SAMEA Iguratimod Sales by Country (2027-2032) & (k pcs) Table 181. SAMEA Iguratimod Sales Price by Country (2021-2026) & (US$/pcs) Table 182. SAMEA Iguratimod Sales Price by Country (2027-2032) & (US$/pcs) Table 183. Brazil Iguratimod Revenue (2021-2032) & (US$ Million) Table 184. Argentina Iguratimod Revenue (2021-2032) & (US$ Million) Table 185. Chile Iguratimod Revenue (2021-2032) & (US$ Million) Table 186. Colombia Iguratimod Revenue (2021-2032) & (US$ Million) Table 187. Peru Iguratimod Revenue (2021-2032) & (US$ Million) Table 188. Saudi Arabia Iguratimod Revenue (2021-2032) & (US$ Million) Table 189. Israel Iguratimod Revenue (2021-2032) & (US$ Million) Table 190. UAE Iguratimod Revenue (2021-2032) & (US$ Million) Table 191. Turkey Iguratimod Revenue (2021-2032) & (US$ Million) Table 192. Iran Iguratimod Revenue (2021-2032) & (US$ Million) Table 193. Egypt Iguratimod Revenue (2021-2032) & (US$ Million) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Iguratimod Distributors List Table 197. Iguratimod Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Iguratimod Image Figure 2. Global Iguratimod Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Iguratimod Market Size Share 2021 VS 2025 VS 2032 Figure 4. 14 Pcs/Box Image Figure 5. 100 Pcs/Box Image Figure 6. Global Iguratimod Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Iguratimod Market Size Share 2021 VS 2025 VS 2032 Figure 8. Antirheumatic Image Figure 9. Immunoregulation Image Figure 10. Others Image Figure 11. Global Iguratimod Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Iguratimod Revenue (2021-2032) & (US$ Million) Figure 13. Global Iguratimod Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Iguratimod Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Iguratimod Revenue Market Share by Region (2021-2032) Figure 16. Global Iguratimod Sales (2021-2032) & (k pcs) Figure 17. Global Iguratimod Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 18. Global Iguratimod Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Iguratimod Sales YoY (2021-2032) & (k pcs) Figure 20. Europe Iguratimod Sales YoY (2021-2032) & (k pcs) Figure 21. China Iguratimod Sales YoY (2021-2032) & (k pcs) Figure 22. Asia (Excluding China) Iguratimod Sales YoY (2021-2032) & (k pcs) Figure 23. South America, Middle East and Africa Iguratimod Sales YoY (2021-2032) & (k pcs) Figure 24. Global Iguratimod Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Iguratimod Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Iguratimod Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Iguratimod Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Iguratimod Revenue Market Share by Type (2021-2032) Figure 30. Global Iguratimod Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 31. Global Iguratimod Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Iguratimod Sales Market Share by Type (2021-2032) Figure 33. Global Iguratimod Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Iguratimod Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Iguratimod Revenue Market Share by Application (2021-2032) Figure 36. Global Iguratimod Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 37. Global Iguratimod Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Iguratimod Sales Market Share by Application (2021-2032) Figure 39. North America Iguratimod Revenue Share by Type (2021-2032) Figure 40. North America Iguratimod Sales Share by Type (2021-2032) Figure 41. North America Iguratimod Revenue Share by Application (2021-2032) Figure 42. North America Iguratimod Sales Share by Application (2021-2032) Figure 43. North America Iguratimod Revenue Share by Country (2021-2032) Figure 44. North America Iguratimod Sales Share by Country (2021-2032) Figure 45. Europe Iguratimod Revenue Share by Type (2021-2032) Figure 46. Europe Iguratimod Sales Share by Type (2021-2032) Figure 47. Europe Iguratimod Revenue Share by Application (2021-2032) Figure 48. Europe Iguratimod Sales Share by Application (2021-2032) Figure 49. Europe Iguratimod Revenue Share by Country (2021-2032) Figure 50. Europe Iguratimod Sales Share by Country (2021-2032) Figure 51. China Iguratimod Revenue Share by Type (2021-2032) Figure 52. China Iguratimod Sales Share by Type (2021-2032) Figure 53. China Iguratimod Revenue Share by Application (2021-2032) Figure 54. China Iguratimod Sales Share by Application (2021-2032) Figure 55. Asia Iguratimod Revenue Share by Type (2021-2032) Figure 56. Asia Iguratimod Sales Share by Type (2021-2032) Figure 57. Asia Iguratimod Revenue Share by Application (2021-2032) Figure 58. Asia Iguratimod Sales Share by Application (2021-2032) Figure 59. Asia Iguratimod Revenue Share by Country (2021-2032) Figure 60. Asia Iguratimod Sales Share by Country (2021-2032) Figure 61. SAMEA Iguratimod Revenue Share by Type (2021-2032) Figure 62. SAMEA Iguratimod Sales Share by Type (2021-2032) Figure 63. SAMEA Iguratimod Revenue Share by Application (2021-2032) Figure 64. SAMEA Iguratimod Sales Share by Application (2021-2032) Figure 65. SAMEA Iguratimod Revenue Share by Country (2021-2032) Figure 66. SAMEA Iguratimod Sales Share by Country (2021-2032) Figure 67. Iguratimod Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Iguratimod Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 14 Pcs/Box
  • 100 Pcs/Box
Applications
  • Antirheumatic
  • Immunoregulation
  • Others
Companies covered
  • Simcere Pharmaceutical
  • Eisai
  • Toyama Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Iguratimod Market by Type
  3. 1.2.1 Global Iguratimod Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 14 Pcs/Box
  5. 1.2.3 100 Pcs/Box
  6. 1.3 Iguratimod Market by Application
  7. 1.3.1 Global Iguratimod Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Antirheumatic
  9. 1.3.3 Immunoregulation
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Iguratimod Market Dynamics
  1. 2.1 Iguratimod Industry Trends
  2. 2.2 Iguratimod Industry Drivers
  3. 2.3 Iguratimod Industry Opportunities and Challenges
  4. 2.4 Iguratimod Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Iguratimod Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Iguratimod Revenue by Region
  3. 3.2.1 Global Iguratimod Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Iguratimod Revenue by Region (2021-2026)
  5. 3.2.3 Global Iguratimod Revenue by Region (2027-2032)
  6. 3.2.4 Global Iguratimod Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Iguratimod Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Iguratimod Sales by Region
  9. 3.4.1 Global Iguratimod Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Iguratimod Sales by Region (2021-2026)
  11. 3.4.3 Global Iguratimod Sales by Region (2027-2032)
  12. 3.4.4 Global Iguratimod Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Iguratimod Revenue by Manufacturers
  2. 4.1.1 Global Iguratimod Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Iguratimod Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Iguratimod Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Iguratimod Sales by Manufacturers
  6. 4.2.1 Global Iguratimod Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Iguratimod Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Iguratimod Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Iguratimod Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Iguratimod Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Iguratimod Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Iguratimod Manufacturers, Product Type & Application
  13. 4.7 Global Iguratimod Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Iguratimod Market CR5 and HHI
  16. 4.8.2 2025 Iguratimod Tier 1, Tier 2, and Tier 3
5 Iguratimod Market by Type
  1. 5.1 Global Iguratimod Revenue by Type
  2. 5.1.1 Global Iguratimod Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Iguratimod Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Iguratimod Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Iguratimod Sales by Type
  6. 5.2.1 Global Iguratimod Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Iguratimod Sales by Type (2021-2032) & (k pcs)
  8. 5.2.3 Global Iguratimod Sales Market Share by Type (2021-2032)
  9. 5.3 Global Iguratimod Price by Type
6 Iguratimod Market by Application
  1. 6.1 Global Iguratimod Revenue by Application
  2. 6.1.1 Global Iguratimod Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Iguratimod Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Iguratimod Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Iguratimod Sales by Application
  6. 6.2.1 Global Iguratimod Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Iguratimod Sales by Application (2021-2032) & (k pcs)
  8. 6.2.3 Global Iguratimod Sales Market Share by Application (2021-2032)
  9. 6.3 Global Iguratimod Price by Application
7 Company Profiles
  1. 7.1 Simcere Pharmaceutical
  2. 7.1.1 Simcere Pharmaceutical Company Information
  3. 7.1.2 Simcere Pharmaceutical Business Overview
  4. 7.1.3 Simcere Pharmaceutical Iguratimod Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Simcere Pharmaceutical Iguratimod Product Portfolio
  6. 7.1.5 Simcere Pharmaceutical Recent Developments
  7. 7.2 Eisai
  8. 7.2.1 Eisai Company Information
  9. 7.2.2 Eisai Business Overview
  10. 7.2.3 Eisai Iguratimod Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eisai Iguratimod Product Portfolio
  12. 7.2.5 Eisai Recent Developments
  13. 7.3 Toyama Chemical
  14. 7.3.1 Toyama Chemical Company Information
  15. 7.3.2 Toyama Chemical Business Overview
  16. 7.3.3 Toyama Chemical Iguratimod Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Toyama Chemical Iguratimod Product Portfolio
  18. 7.3.5 Toyama Chemical Recent Developments
8 North America
  1. 8.1 North America Iguratimod Market Size by Type
  2. 8.1.1 North America Iguratimod Revenue by Type (2021-2032)
  3. 8.1.2 North America Iguratimod Sales by Type (2021-2032)
  4. 8.1.3 North America Iguratimod Price by Type (2021-2032)
  5. 8.2 North America Iguratimod Market Size by Application
  6. 8.2.1 North America Iguratimod Revenue by Application (2021-2032)
  7. 8.2.2 North America Iguratimod Sales by Application (2021-2032)
  8. 8.2.3 North America Iguratimod Price by Application (2021-2032)
  9. 8.3 North America Iguratimod Market Size by Country
  10. 8.3.1 North America Iguratimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Iguratimod Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Iguratimod Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Iguratimod Market Size by Type
  2. 9.1.1 Europe Iguratimod Revenue by Type (2021-2032)
  3. 9.1.2 Europe Iguratimod Sales by Type (2021-2032)
  4. 9.1.3 Europe Iguratimod Price by Type (2021-2032)
  5. 9.2 Europe Iguratimod Market Size by Application
  6. 9.2.1 Europe Iguratimod Revenue by Application (2021-2032)
  7. 9.2.2 Europe Iguratimod Sales by Application (2021-2032)
  8. 9.2.3 Europe Iguratimod Price by Application (2021-2032)
  9. 9.3 Europe Iguratimod Market Size by Country
  10. 9.3.1 Europe Iguratimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Iguratimod Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Iguratimod Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Iguratimod Market Size by Type
  2. 10.1.1 China Iguratimod Revenue by Type (2021-2032)
  3. 10.1.2 China Iguratimod Sales by Type (2021-2032)
  4. 10.1.3 China Iguratimod Price by Type (2021-2032)
  5. 10.2 China Iguratimod Market Size by Application
  6. 10.2.1 China Iguratimod Revenue by Application (2021-2032)
  7. 10.2.2 China Iguratimod Sales by Application (2021-2032)
  8. 10.2.3 China Iguratimod Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Iguratimod Market Size by Type
  2. 11.1.1 Asia Iguratimod Revenue by Type (2021-2032)
  3. 11.1.2 Asia Iguratimod Sales by Type (2021-2032)
  4. 11.1.3 Asia Iguratimod Price by Type (2021-2032)
  5. 11.2 Asia Iguratimod Market Size by Application
  6. 11.2.1 Asia Iguratimod Revenue by Application (2021-2032)
  7. 11.2.2 Asia Iguratimod Sales by Application (2021-2032)
  8. 11.2.3 Asia Iguratimod Price by Application (2021-2032)
  9. 11.3 Asia Iguratimod Market Size by Country
  10. 11.3.1 Asia Iguratimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Iguratimod Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Iguratimod Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Iguratimod Market Size by Type
  2. 12.1.1 SAMEA Iguratimod Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Iguratimod Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Iguratimod Price by Type (2021-2032)
  5. 12.2 SAMEA Iguratimod Market Size by Application
  6. 12.2.1 SAMEA Iguratimod Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Iguratimod Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Iguratimod Price by Application (2021-2032)
  9. 12.3 SAMEA Iguratimod Market Size by Country
  10. 12.3.1 SAMEA Iguratimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Iguratimod Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Iguratimod Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Iguratimod Value Chain Analysis
  2. 13.1.1 Iguratimod Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Iguratimod Production Mode & Process
  6. 13.2 Iguratimod Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Iguratimod Distributors
  9. 13.2.3 Iguratimod Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst